Organigram Holdings

OGI-X

Analysis and Opinions about OGI-X

Signal
Opinion
Expert
WATCH
WATCH
December 9, 2019
They have done an excellent job executing. They have been working on a number of different products. They have been a leader in Canada and will continue. It will depend what happens with the new products.
Show full opinionHide full opinion
They have done an excellent job executing. They have been working on a number of different products. They have been a leader in Canada and will continue. It will depend what happens with the new products.
DON'T BUY
DON'T BUY
November 1, 2019
All the cannabis stocks are down 50-80% this year. The legal market in Canada has proven to be a bust as the retails stores have not come online as fast as people would have liked and the margins are not there. He would not recommend buying it here. He would short all these stocks if it were not for the cost of borrowing to short them. He is skeptical about the health claims of CBD.
Show full opinionHide full opinion
All the cannabis stocks are down 50-80% this year. The legal market in Canada has proven to be a bust as the retails stores have not come online as fast as people would have liked and the margins are not there. He would not recommend buying it here. He would short all these stocks if it were not for the cost of borrowing to short them. He is skeptical about the health claims of CBD.
TOP PICK
TOP PICK
October 17, 2018

This trades at low valuations – 12 times earnings. A low cost producer in New Brunswick. Yield 0%. (Analysts’ price target is $9.09)

Show full opinionHide full opinion

This trades at low valuations – 12 times earnings. A low cost producer in New Brunswick. Yield 0%. (Analysts’ price target is $9.09)

DON'T BUY
DON'T BUY
June 29, 2018

Contender, go by the wayside, or be acquired? Be careful, takeout premium is built in. If no takeout, there could be a blow up in the stock. Stuck in no man’s land, no R&D on pharmaceutical side, no export agreements. Tough for them to compete in exports and pharmaceuticals when the market price of wholesale marijuana reaches a plateau in a year or two.

Show full opinionHide full opinion

Contender, go by the wayside, or be acquired? Be careful, takeout premium is built in. If no takeout, there could be a blow up in the stock. Stuck in no man’s land, no R&D on pharmaceutical side, no export agreements. Tough for them to compete in exports and pharmaceuticals when the market price of wholesale marijuana reaches a plateau in a year or two.

PAST TOP PICK
PAST TOP PICK
February 28, 2018

(A Top Pick March 10/17. Up 63%) He says this cannabis producer has done well, but still does not get the recognition it deserves – especially on the east coast.

Show full opinionHide full opinion
Organigram Holdings (OGI-X)
February 28, 2018

(A Top Pick March 10/17. Up 63%) He says this cannabis producer has done well, but still does not get the recognition it deserves – especially on the east coast.

DON'T BUY
DON'T BUY
January 17, 2018

(Market Call Minute.) Until proven otherwise, marijuana producers are producing an agricultural commodity and will earn low returns on investment capital. It's a business model that’s unproven, and he would steer clear.

Show full opinionHide full opinion

(Market Call Minute.) Until proven otherwise, marijuana producers are producing an agricultural commodity and will earn low returns on investment capital. It's a business model that’s unproven, and he would steer clear.

COMMENT
COMMENT
December 4, 2017

Chart shows some pretty big swings. What is positive currently is that there is nice little upward trend, but is probably going to be in jeopardy based on the gravity affect. If it got below $2.70, he would say there is probably something wrong with the story. When you have a new industry like this, you will often get some rationalization, and in this new cycle, he expects it will happen much sooner. It’s really hard to tell which are the winners.

Show full opinionHide full opinion

Chart shows some pretty big swings. What is positive currently is that there is nice little upward trend, but is probably going to be in jeopardy based on the gravity affect. If it got below $2.70, he would say there is probably something wrong with the story. When you have a new industry like this, you will often get some rationalization, and in this new cycle, he expects it will happen much sooner. It’s really hard to tell which are the winners.

BUY
BUY
June 22, 2017

(Market Call Minute) They had all these issues with the recall, but it is probably one of the cheapest ones out there.

Show full opinionHide full opinion

(Market Call Minute) They had all these issues with the recall, but it is probably one of the cheapest ones out there.

COMMENT
COMMENT
April 26, 2017

Marijuana stocks sold off a few days before the legislation was getting tabled. There is a lot of supply of stock coming on right now with a lot of companies going public. After everything they’ve gone through, he still thinks they are one of the best operators, and that the stock is worth more than the current price. Their relationship with TGS out of the US is really interesting, where they are looking at the extracts and other products. That is probably not going to come into play for the company, but certainly down the road with the next step of legalization, it will.

Show full opinionHide full opinion

Marijuana stocks sold off a few days before the legislation was getting tabled. There is a lot of supply of stock coming on right now with a lot of companies going public. After everything they’ve gone through, he still thinks they are one of the best operators, and that the stock is worth more than the current price. Their relationship with TGS out of the US is really interesting, where they are looking at the extracts and other products. That is probably not going to come into play for the company, but certainly down the road with the next step of legalization, it will.

COMMENT
COMMENT
April 11, 2017

Marijuana stocks are tough to get a read on. They’ve all moved in a similar direction. He doesn’t know what the industry is going to look like or what the regulation is going to be like and how everything is going to play out. This is an industry in its infancy, but as a portfolio manager, it is not something he would look at. Once there is some clarification on what future legislation is going to look like, federally and provincially, then it will be a lot easier to determine which stocks are the ones to own.

Show full opinionHide full opinion

Marijuana stocks are tough to get a read on. They’ve all moved in a similar direction. He doesn’t know what the industry is going to look like or what the regulation is going to be like and how everything is going to play out. This is an industry in its infancy, but as a portfolio manager, it is not something he would look at. Once there is some clarification on what future legislation is going to look like, federally and provincially, then it will be a lot easier to determine which stocks are the ones to own.

TOP PICK
TOP PICK
March 10, 2017

He likes the prospects and just added to his holdings recently. This will be a core holding in his marijuana fund portfolio. It is the only one in the Maritimes. (Analysts’ price target is $4.10.)

Show full opinionHide full opinion

He likes the prospects and just added to his holdings recently. This will be a core holding in his marijuana fund portfolio. It is the only one in the Maritimes. (Analysts’ price target is $4.10.)

COMMENT
COMMENT
November 16, 2016

This is going to be a massive growing sector. Legislation has not been tabled yet, and all these stocks have been running up on anticipation of the government’s task force reporting later this month. It is probably going to be about nothing, and doesn’t think the public is going to get access to it. You have to watch for when the legislation gets tabled, probably in 2017. Valuations have run up so much they have to be dangerous.

Show full opinionHide full opinion
Organigram Holdings (OGI-X)
November 16, 2016

This is going to be a massive growing sector. Legislation has not been tabled yet, and all these stocks have been running up on anticipation of the government’s task force reporting later this month. It is probably going to be about nothing, and doesn’t think the public is going to get access to it. You have to watch for when the legislation gets tabled, probably in 2017. Valuations have run up so much they have to be dangerous.

COMMENT
COMMENT
October 26, 2016

(Market Call Minute.) A medical marijuana company and they have some advantages. While the sector is ahead of itself right now, this would be a longer-term Buy.

Show full opinionHide full opinion

(Market Call Minute.) A medical marijuana company and they have some advantages. While the sector is ahead of itself right now, this would be a longer-term Buy.

DON'T BUY
DON'T BUY
August 3, 2016

(Market Call Minute.) There are so many marijuana companies that whole sector should be avoided. It is a ridiculous valuation for a commodity-based product. There will be some companies that will make money, but if you cannot predict which ones, then stay away.

Show full opinionHide full opinion

(Market Call Minute.) There are so many marijuana companies that whole sector should be avoided. It is a ridiculous valuation for a commodity-based product. There will be some companies that will make money, but if you cannot predict which ones, then stay away.

Showing 1 to 14 of 14 entries
  • «
  • 1
  • »